Perspective Therapeutics (CATX) Other financing activities (2010 - 2026)

Perspective Therapeutics (CATX) posted Other financing activities of $290000.0 for Q1 2026, up 178.17% sequentially from -$371000.0 in Q4 2025.

Perspective Therapeutics (CATX) Other financing activities (2010 - 2026) Analysis & Trends

Perspective Therapeutics has reported Other financing activities for 15 years, with the latest figure at $290000.0 in Q1 2026.

Quarterly Other financing activities changed N/A year-over-year to $290000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $290000.0 (down 74.27% YoY) and the FY2024 annual result came in at $1.3 million, changed N/A from the prior year.
Other financing activities rose to $290000.0 in Q1 2026 per CATX's latest filing, from -$371000.0 in the prior quarter.
Over five years, Other financing activities peaked at $773000.0 in Q3 2024 and troughed at -$532000.0 in Q3 2023.
A 5-year average of $114166.7 and a median of $78000.0 in 2022 frame the typical range for Other financing activities.
The widest YoY moves for Other financing activities: up 330.3% in 2023, down 2000.0% in 2023.
Over 5 years, Other financing activities stood at $30000.0 in 2022, then slumped by 1873.33% to -$532000.0 in 2023, then soared by 167.11% to $357000.0 in 2024, then slumped by 203.92% to -$371000.0 in 2025, then surged by 178.17% to $290000.0 in 2026.
According to Business Quant data, Other financing activities over the past three periods registered $290000.0, -$371000.0, and $371000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Perspective Therapeutics	389.10 Mn	389.10 Mn	-

Download Data